Published in World J Surg on July 01, 2008
German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg (2013) 1.23
German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease. Langenbecks Arch Surg (2011) 1.02
Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules. World J Surg (2010) 0.97
Is fine-needle aspiration cytology for thyroid nodules a routine and safe procedure? A series of emergency cervicotomies following FNAC. Langenbecks Arch Surg (2010) 0.77
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2006) 12.23
Management of a solitary thyroid nodule. N Engl J Med (1993) 7.15
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol (2006) 6.57
Clinical practice. The thyroid nodule. N Engl J Med (2004) 4.84
Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med (1993) 4.09
Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1989) 3.78
Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer (2007) 3.20
Aspiration biopsy cytology (ABC) in nodules of the thyroid gland suspected to be malignant. Surg Clin North Am (1979) 2.96
Evidence based medicine: what it is and what it isn't. 1996. Clin Orthop Relat Res (2007) 2.03
Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab (2002) 1.76
Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc (1994) 1.49
Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls. Endocr Pract (2003) 1.41
Distinct diagnostic criteria for ultrasonographic examination of papillary thyroid carcinoma: a multicenter study. Thyroid (2005) 1.36
Sources of diagnostic error in fine needle aspiration of the thyroid. Cancer (1989) 1.34
Inadequate rates are lower when FNAC samples are taken by cytopathologists. Cytopathology (2003) 1.33
Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. Clin Lab Med (1993) 1.33
Fine-needle aspiration of the thyroid: an overview. Cytojournal (2005) 1.29
Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clin Endocrinol (Oxf) (2007) 1.21
Diagnostic accuracy of fine-needle aspiration biopsy is determined by physician training in sampling technique. Cancer (2001) 1.14
Intrathyroid hemorrhage and acute upper airway obstruction after fine needle aspiration of the thyroid gland. Laryngoscope (2006) 1.12
Comparison of fine-needle-nonaspiration with fine-needle-aspiration technique in the cytologic studies of thyroid nodules. Endocr Pathol (2003) 1.11
Reporting thyroid fine-needle aspiration: literature review and a proposal. Diagn Cytopathol (2006) 1.10
Perceptions of diagnostic terminology and cytopathologic reporting of fine-needle aspiration biopsies of thyroid nodules: a survey of clinicians and pathologists. Thyroid (2006) 1.09
Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol (2006) 1.04
Fine-needle aspiration of thyroid nodules: correlation between cytology and histology and evaluation of discrepant cases. Cancer (1997) 1.00
Fine needle aspiration cytology. Cytopathology (2003) 0.99
HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Mod Pathol (1997) 0.98
Role of ultrasonography in predicting malignancy in patients with thyroid nodules. World J Surg (2007) 0.90
Diagnostic accuracy of fine needle aspiration cytology of the thyroid: impact of ultrasonography and ultrasonographically guided aspiration. Acta Cytol (2001) 0.88
Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management. World J Surg (2000) 0.86
Analysis of inconclusive fine-needle aspiration of thyroid follicular lesions. Endocr Pathol (2003) 0.86
Fine needle aspiration cytology and immunocytochemistry in the diagnosis of lymphoid lesions of the thyroid gland. Acta Cytol (1989) 0.85
A PCR-based expression signature of malignancy in follicular thyroid tumors. Endocr Relat Cancer (2007) 0.84
Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid (2007) 0.83
MIB-1 index in thyroid tumors: a predictor of the clinical course in papillary thyroid carcinoma. Thyroid (2003) 0.81
Thyroid nodules indeterminate by needle biopsy. Am J Surg (1983) 0.80
Surgical treatment of solitary thyroid nodules via fine-needle aspiration biopsy and frozen-section analysis. Ann Surg Oncol (2006) 0.80
Has fine-needle aspiration biopsy changed thyroid practice? Endocr Pract (2004) 0.79
Improved FNA cytology results with a near patient diagnosis service for non-breast lesions. J Clin Pathol (1998) 0.79
1. Introduction to aspiration biopsy. Monogr Clin Cytol (1974) 0.78
[Thyroid nodule pathology: proposal of a diagnostic approach based on the experience of a thyroid disease unit]. Chir Ital (2001) 0.77
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res (2005) 8.73
Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res (2006) 4.25
PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer. Clin Cancer Res (2007) 3.51
Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients. Breast Cancer Res (2005) 2.48
Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer (2006) 2.46
Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression. J Clin Oncol (2012) 2.00
Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma. Thyroid (2010) 1.51
Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women. Menopause (2007) 1.50
Diagnosis and grading of chondrosarcomas on FNA biopsy material. Diagn Cytopathol (2003) 1.41
Akt kinases in breast cancer and the results of adjuvant therapy. Breast Cancer Res (2003) 1.41
[Diagnostic problems in hypothyroidism: is increased lymphocyte count in fine needle biopsy an indication for treatment?]. Lakartidningen (2006) 1.40
The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer (2011) 1.35
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen. Breast Cancer Res Treat (2010) 1.31
Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS One (2012) 1.30
The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy. Endocr Relat Cancer (2007) 1.30
Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer. Breast Cancer Res Treat (2010) 1.27
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression. Breast Cancer Res Treat (2010) 1.20
Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors. J Clin Endocrinol Metab (2003) 1.17
Proteinase K added to the extraction procedure markedly increases RNA yield from primary breast tumors for use in microarray studies. Clin Chem (2004) 1.13
Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer. Breast Cancer Res (2010) 1.12
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit. Breast Cancer Res Treat (2012) 1.10
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study. BMC Med (2006) 1.08
Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer. Genes Chromosomes Cancer (2002) 1.08
Estrogen receptor-alpha phosphorylation at serine 305, nuclear p21-activated kinase 1 expression, and response to tamoxifen in postmenopausal breast cancer. Clin Cancer Res (2010) 1.05
Intact Mre11/Rad50/Nbs1 complex predicts good response to radiotherapy in early breast cancer. Int J Radiat Oncol Biol Phys (2007) 1.03
The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer. Radiother Oncol (2007) 1.03
Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients. Clin Cancer Res (2009) 1.02
TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA. Cancer (2014) 0.99
Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer. Int J Oncol (2008) 0.98
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials. Breast Cancer Res (2013) 0.97
Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogene. Oncogene (2005) 0.96
Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifen. Eur J Cancer (2006) 0.95
Amplification of HSD17B1 and ERBB2 in primary breast cancer. Oncogene (2003) 0.94
Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma. Endocr Relat Cancer (2013) 0.93
The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion. J Clin Endocrinol Metab (2005) 0.92
Cytoplasmic p21WAF1/CIP1 correlates with Akt activation and poor response to tamoxifen in breast cancer. Int J Oncol (2006) 0.91
A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas. Hematol J (2004) 0.89
Fine-needle aspiration cytology and immunocytochemistry of orbital masses. Diagn Cytopathol (2006) 0.88
Proteomic profiling of follicular and papillary thyroid tumors. Eur J Endocrinol (2012) 0.87
Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm. World J Surg (2011) 0.87
Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance. Breast Cancer Res Treat (2005) 0.87
Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization. BMC Cancer (2013) 0.87
Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma. Cytometry B Clin Cytom (2005) 0.86
Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma. J Clin Endocrinol Metab (2014) 0.86
Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer. Breast Cancer Res Treat (2010) 0.86
Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution. J Surg Oncol (2012) 0.85
A PCR-based expression signature of malignancy in follicular thyroid tumors. Endocr Relat Cancer (2007) 0.84
Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer. Oncol Rep (2004) 0.84
Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer (2003) 0.84
An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women. Menopause (2007) 0.84
Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients. Acta Oncol (2004) 0.84
Vitamin D supplementation after parathyroidectomy: effect on bone mineral density-a randomized double-blind study. J Bone Miner Res (2014) 0.84
Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology. Eur J Endocrinol (2005) 0.83
Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours. Melanoma Res (2010) 0.83
Expression of COX-2 and steroid converting enzymes in breast cancer. Oncol Rep (2006) 0.82
MIB-1 index in thyroid tumors: a predictor of the clinical course in papillary thyroid carcinoma. Thyroid (2003) 0.81
Diagnosis and prognosis of iatrogenic injury of the recurrent laryngeal nerve. Ann Otol Rhinol Laryngol (2009) 0.81
Dynamic MRI and fine needle aspiration cytology in the evaluation of soft tissue lesions. Skeletal Radiol (2003) 0.81
Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind study. Eur J Endocrinol (2013) 0.81
Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma. Eur J Endocrinol (2012) 0.81
CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12. Int J Mol Med (2005) 0.81
Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism. Am J Pathol (2002) 0.80
Proliferation rate, hormone receptor status and p53 expression in skeletal metastasis of breast carcinoma. Acta Oncol (2004) 0.80
Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer. Breast Cancer Res Treat (2014) 0.80
Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study. Fertil Steril (2006) 0.79
Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer. Int J Oncol (2009) 0.79
Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cells. Anticancer Drugs (2014) 0.78
17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer. PLoS One (2012) 0.78
Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer. Eur J Cancer (2013) 0.78
Evidence for Ca(2+)-regulated ATP release in gastrointestinal stromal tumors. Exp Cell Res (2013) 0.78
[Antithyroid drug-induced agranulocytosis. A rare but dreaded condition]. Lakartidningen (2009) 0.78
Difference in hormone receptor content in breast cancers from Vietnamese and Swedish women. Acta Oncol (2011) 0.78
Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy. Int J Oncol (2009) 0.77
Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors. Int J Oncol (2005) 0.77
Combined radiology and cytology in the diagnosis of bone lesions: a retrospective study of 370 cases. Acta Orthop Scand (2004) 0.77
Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys. Am J Obstet Gynecol (2005) 0.76
Cyclin D2 expression in familial and sporadic breast cancer. Oncol Rep (2002) 0.76
Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy. Clin Endocrinol (Oxf) (2014) 0.76
MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas. Eur J Endocrinol (2014) 0.76
Breast cancer associated with primary hyperparathyroidism: a nested case control study. Clin Epidemiol (2011) 0.75
Hürthle cell carcinoma: time for a drastic change? Cancer (2002) 0.75
Diagnosis of high-grade osteosarcoma by radiology and cytology: a retrospective study of 52 cases. Sarcoma (2004) 0.75
High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas. J Clin Endocrinol Metab (2005) 0.75
Expression of the CD117, COX-2 and HSP90 antigens and cell proliferation in fine-needle-aspirated cells from metastatic melanomas. Anticancer Res (2009) 0.75
Novel therapeutic strategies for neuroendocrine tumours--can eminence replace evidence? Acta Oncol (2008) 0.75
Sixten Franzen, MD, PhD, Honorary Professor, 1919-2008. Cancer (2008) 0.75
HER2 status in operable breast cancers from Vietnamese women: Analysis by immunohistochemistry (IHC) and automated silver enhanced in situ hybridization (SISH). Acta Oncol (2011) 0.75
A Review of the Use of Fine-Needle Aspiration Biopsy of Mammary Tumors for Diagnosis and Research. Acta Cytol (2017) 0.75
Long-term breast cancer survival in Vietnamese women. Breast J (2014) 0.75
Assessment of V600E mutation of BRAF gene and rate of cell proliferation using fine-needle aspirates from metastatic melanomas. Anticancer Res (2010) 0.75